CCMG
MRK icon

Connecticut Capital Management Group’s Merck MRK Stock Holding History

Connecticut Capital Management Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Sell
3,415
-2
-0.1% -$234 0.35% 57
2026
Q1 		$411K Hold
3,417
– – 0.39% 51
2025
Q4 		$360K Buy
+3,417
New +$321K 0.34% 53

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Connecticut Capital Management Group's MRK Position: Q2 2026 in Review

Connecticut Capital Management Group reduced its Merck (MRK) stake by 0.06% in Q2 2026, selling an estimated $234 and leaving 3,415 shares worth $439K. The position accounts for 0.35% of the portfolio, ranked #57.

Connecticut Capital Management Group first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,815 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Connecticut Capital Management Group held 3,415 shares of Merck worth $439K as of Q2 2026.
  • Connecticut Capital Management Group sold 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.35% of Connecticut Capital Management Group's portfolio in Q2 2026, its #57 holding.
  • Connecticut Capital Management Group first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,815 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Connecticut Capital Management Group's 13F filing for Q2 2026, filed 20 Jul 2026.